Literature DB >> 4067056

Mohs surgery for periocular basal cell carcinomas.

P Robins, R Rodríguez-Sains, H Rabinovitz, D Rigel.   

Abstract

Cure rates for 631 periocular basal cell carcinomas treated by Mohs surgery proved to be 98.1% for primary lesions and 93.6% for previously treated lesions. All recurrences of primary lesions post-Mohs surgery were located in the medial canthus. Among lesions previously treated, recurrence rates after Mohs surgery were twice as high for medial canthal lesions as for other periocular basal cell carcinomas, 9.5 and 4.5%, respectively. A threefold increased risk of recurrence was observed for medial canthal lesions (post-Mohs surgery) previously treated by radiation as compared to all other treatment modalities. This high recurrence rate may reflect past practices of treating large medial canthal basal cell carcinomas with radiation rather than by other means. Results of our study indicate that primary basal cell carcinomas in the medial canthus can be treated by microscopically controlled excision with excellent results.

Entities:  

Mesh:

Year:  1985        PMID: 4067056     DOI: 10.1111/j.1524-4725.1985.tb03098.x

Source DB:  PubMed          Journal:  J Dermatol Surg Oncol        ISSN: 0148-0812


  6 in total

1.  Malignant eyelid tumors: Are intra-operative rapid frozen section and permanent section diagnoses of surgical margins concordant?

Authors:  Swathi Kaliki; Sasi Pyda; Nupur Goel; Tarjani Vivek Dave; Milind N Naik; Dilip K Mishra
Journal:  Int Ophthalmol       Date:  2018-12-08       Impact factor: 2.031

2.  Orbital exenteration: a 13 year Manchester experience.

Authors:  I Rahman; A E Cook; B Leatherbarrow
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

3.  Mohs micrographic surgery for periocular skin tumours in Ireland.

Authors:  M P Treacy; N C Wynne; J L Gale; E Duignan; B Moran; A M Flynn; P Ormond; R Barry; R Khan; P Moriarty; L Cassidy
Journal:  Ir J Med Sci       Date:  2015-07-11       Impact factor: 1.568

4.  Surgery for primary basal cell carcinoma including the eyelid margins with intraoperative frozen section control: comparative interventional study with a minimum clinical follow up of 5 years.

Authors:  R M Conway; S Themel; L M Holbach
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

5.  Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study.

Authors:  M F Avril; A Auperin; A Margulis; A Gerbaulet; P Duvillard; E Benhamou; J C Guillaume; R Chalon; J Y Petit; H Sancho-Garnier; M Prade; J Bouzy; D Chassagne
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  The Importance of Frozen Section-Controlled Excision in Recurrent Basal Cell Carcinoma of the Eyelids.

Authors:  Berna Şahan; Ferda Çiftçi; Ferda Özkan; Vildan Öztürk
Journal:  Turk J Ophthalmol       Date:  2016-12-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.